menu
    • menu

    Company profile for TILT Biotherapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor T-cell therapy and checkpoint inhibitors with oncolytic viruses. TILT Biotherapeutics is developing a new treatment for cancer using oncolytic immunotherapy. Advanced solid tumors are difficult to treat with limited treatment options available. However, preclinical data on TILT® technology, alone and in combination with other immuno...
    TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor T-cell therapy and checkpoint inhibitors with oncolytic viruses. TILT Biotherapeutics is developing a new treatment for cancer using oncolytic immunotherapy. Advanced solid tumors are difficult to treat with limited treatment options available. However, preclinical data on TILT® technology, alone and in combination with other immunotherapy agents (such as T-cells and checkpoint inhibitors) have demonstrated 100% cure rates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TILT BiotherapeuticsFinland Flag
    Country
    Country
    Finland
    Address
    Address
    Haartmaninkatu 3, 4th floor, C-wing 00290 Helsinki
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tiltbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tilt Biotherapeutics Closes USD 25M Series B Financing
    Tilt Biotherapeutics Closes USD 25M Series B Financing

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3079780/0/en/TILT-Biotherapeutics-Announces-Closing-of-USD-25-Million-Series-B-Financing.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    TILT Bio Updates International Cancer Immunotherapy Trial
    TILT Bio Updates International Cancer Immunotherapy Trial

    05 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/05/2992081/0/en/TILT-Biotherapeutics-Provides-Update-on-International-Clinical-Trial-Progress-with-Intravenous-Delivery-Regimen-for-Cancer-Immunotherapies.html

    GLOBENEWSWIRE
    05 Dec 2024
    Share Share
    TILT Presents TILT-123 IV Delivery Data At ESMO 2024
    TILT Presents TILT-123 IV Delivery Data At ESMO 2024

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942525/0/en/TILT-Biotherapeutics-Presents-Clinical-Data-on-TILT-123-After-Fully-Intravenous-Delivery-Regimen-at-ESMO-2024.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    TILT Bio: TILT-123 Ovarian Cancer Data Presented At ASCO 2024
    TILT Bio: TILT-123 Ovarian Cancer Data Presented At ASCO 2024

    28 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/28/2888715/0/en/TILT-Biotherapeutics-Presents-Clinical-Data-on-TILT-123-in-Ovarian-Cancer-at-ASCO-2024.html

    GLOBENEWSWIRE
    28 May 2024
    Share Share
    TILT Biotherapeutics Presents TILT-123 Data with KEYTRUDA®
    TILT Biotherapeutics Presents TILT-123 Data with KEYTRUDA®

    10 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/10/2860497/0/en/TILT-Biotherapeutics-Presents-Clinical-Data-on-TILT-123-in-Combination-with-KEYTRUDA-pembrolizumab-for-Ovarian-Cancer-at-AACR-2024.html

    GLOBENEWSWIRE
    10 Apr 2024
    Share Share
    TILT Bio Awarded USD 2M Grant for Ovarian Cancer Immunotherapy Research
    TILT Bio Awarded USD 2M Grant for Ovarian Cancer Immunotherapy Research

    14 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/14/2828826/0/en/TILT-Biotherapeutics-Awarded-USD-2M-Grant-from-US-Department-of-Defense-for-Ovarian-Cancer-Immunotherapy-Research.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search